1. Home
  2. OCS vs XPRO Comparison

OCS vs XPRO Comparison

Compare OCS & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • XPRO
  • Stock Information
  • Founded
  • OCS 2003
  • XPRO 1938
  • Country
  • OCS Switzerland
  • XPRO United States
  • Employees
  • OCS N/A
  • XPRO N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • XPRO Oilfield Services/Equipment
  • Sector
  • OCS Health Care
  • XPRO Energy
  • Exchange
  • OCS Nasdaq
  • XPRO Nasdaq
  • Market Cap
  • OCS 1.0B
  • XPRO 1.1B
  • IPO Year
  • OCS N/A
  • XPRO 2013
  • Fundamental
  • Price
  • OCS $19.00
  • XPRO $9.01
  • Analyst Decision
  • OCS Strong Buy
  • XPRO Buy
  • Analyst Count
  • OCS 3
  • XPRO 3
  • Target Price
  • OCS $35.33
  • XPRO $12.00
  • AVG Volume (30 Days)
  • OCS 27.1K
  • XPRO 1.2M
  • Earning Date
  • OCS 08-26-2025
  • XPRO 07-24-2025
  • Dividend Yield
  • OCS N/A
  • XPRO N/A
  • EPS Growth
  • OCS N/A
  • XPRO N/A
  • EPS
  • OCS N/A
  • XPRO 0.58
  • Revenue
  • OCS $847,333.00
  • XPRO $1,720,185,000.00
  • Revenue This Year
  • OCS $18.70
  • XPRO N/A
  • Revenue Next Year
  • OCS $1,059.78
  • XPRO $4.25
  • P/E Ratio
  • OCS N/A
  • XPRO $15.49
  • Revenue Growth
  • OCS N/A
  • XPRO 10.48
  • 52 Week Low
  • OCS $10.79
  • XPRO $6.70
  • 52 Week High
  • OCS $23.08
  • XPRO $24.50
  • Technical
  • Relative Strength Index (RSI)
  • OCS 46.89
  • XPRO 52.31
  • Support Level
  • OCS $18.87
  • XPRO $8.42
  • Resistance Level
  • OCS $19.75
  • XPRO $8.85
  • Average True Range (ATR)
  • OCS 0.43
  • XPRO 0.46
  • MACD
  • OCS -0.11
  • XPRO -0.02
  • Stochastic Oscillator
  • OCS 32.43
  • XPRO 48.50

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About XPRO Expro Group Holdings N.V.

Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.

Share on Social Networks: